19:48 GMT26 February 2021
Listen Live
    Middle East
    Get short URL
    2010
    Subscribe

    MOSCOW (Sputnik) - The COVID-19 vaccine developed by Pfizer and BioNTech pharmaceutical companies has demonstrated 89.4% efficacy against the transmission of SARS-CoV-2, Der Spiegel reported on Sunday, citing scientific research conducted by the Israeli Health Ministry.

    The news outlet stressed that Israel already vaccinated about one-third of its population that allowed scientists to carry out the research on the efficacy of the Pfizer/BioNTech vaccine, which covered roughly 1.7 million inoculated people.

    According to the magazine, BioNTech CEO Ugur Sahin expected that the vaccine could prevent up to 60 percent of transmissions. However, the research has demonstrated that the vaccine is far more efficient.

    The news outlet added that the results of the research were not officially published yet, that was why Pfizer and BioNTech did not comment on the fresh data on their vaccine.

    Israel began its mass vaccination campaign on 20 December. To date, nearly half of the country's 9.3-million population has received at least one shot of the Pfizer coronavirus vaccine. The country has confirmed 744,513 COVID-19 cases, with 5,526 deaths, according to John Hopkins University.

    Tags:
    Israel, vaccine, Pfizer
    Community standardsDiscussion